Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.

Acta Neuropathologica
Michael WellerGuido Reifenberger

Abstract

Cerebral gliomas of World Health Organization (WHO) grade II and III represent a major challenge in terms of histological classification and clinical management. Here, we asked whether large-scale genomic and transcriptomic profiling improves the definition of prognostically distinct entities. We performed microarray-based genome- and transcriptome-wide analyses of primary tumor samples from a prospective German Glioma Network cohort of 137 patients with cerebral gliomas, including 61 WHO grade II and 76 WHO grade III tumors. Integrative bioinformatic analyses were employed to define molecular subgroups, which were then related to histology, molecular biomarkers, including isocitrate dehydrogenase 1 or 2 (IDH1/2) mutation, 1p/19q co-deletion and telomerase reverse transcriptase (TERT) promoter mutations, and patient outcome. Genomic profiling identified five distinct glioma groups, including three IDH1/2 mutant and two IDH1/2 wild-type groups. Expression profiling revealed evidence for eight transcriptionally different groups (five IDH1/2 mutant, three IDH1/2 wild type), which were only partially linked to the genomic groups. Correlation of DNA-based molecular stratification with clinical outcome allowed to define three major p...Continue Reading

References

Apr 19, 2005·Genes, Chromosomes & Cancer·Boris ZielinskiPeter Lichter
Mar 22, 2006·International Journal of Cancer. Journal International Du Cancer·Bjoern TewsPeter Lichter
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Intergroup Radiation Therapy Oncology Group Trial 9402Walter Curran
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Oct 17, 2007·Methods of Information in Medicine·M KreuzD Hasenclever
Oct 7, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael WellerMarkus Loeffler
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jörg FelsbergMichael C Sabel
Nov 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang WickMichael Weller
Nov 4, 2010·Nature Reviews. Neurology·T David Bourne, David Schiff
Jun 1, 2011·Cellular Oncology (Dordrecht)·Elisabeth J ShawCarol Walker
Jul 29, 2011·BMC Bioinformatics·Henry WirthHans Binder
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentKhê Hoang-Xuan
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory CairncrossMinesh Mehta
Dec 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroko Ohgaki, Paul Kleihues
Jul 3, 2013·Nature Genetics·David T W JonesUNKNOWN International Cancer Genome Consortium PedBrain Tumor Project
Jul 31, 2013·The Lancet Oncology·Michael WellerRoger Stupp
Oct 22, 2013·Oncotarget·Patrick J KillelaHai Yan
Oct 25, 2013·Acta Neuropathologica·Christian KoelscheAndreas von Deimling
Feb 12, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Gregory CairncrossWalter J Curran
Mar 13, 2014·International Journal of Cancer. Journal International Du Cancer·Guido ReifenbergerUNKNOWN German Glioma Network
Jul 6, 2014·Brain Pathology·David N LouisUNKNOWN International Society Of Neuropathology--Haarlem

❮ Previous
Next ❯

Citations

Jun 30, 2015·Expert Review of Anticancer Therapy·Agusti AlentornSantosh Kesari
Jan 12, 2016·Current Neurology and Neuroscience Reports·Emilie Le RhunMarc C Chamberlain
Dec 25, 2015·Acta Neuropathologica Communications·Kaspar DraaismaPim J French
Jul 19, 2015·Neuro-oncology·Matthew S WaitkusHai Yan
Sep 16, 2015·Nature Reviews. Neurology·Manfred Westphal, Katrin Lamszus
Jun 20, 2015·Acta Neuropathologica·David E ReussAndreas von Deimling
Jan 1, 2015·Nature Reviews. Disease Primers·Michael WellerGuido Reifenberger
Jun 12, 2016·Briefings in Functional Genomics·Veronique G LeBlanc, Marco A Marra
Jun 14, 2016·Brain Tumor Pathology·Kenta MasuiPaul S Mischel
Jul 3, 2016·Neuro-oncology·Wolfgang WickUNKNOWN Neurooncology Working Group (NOA) of the German Cancer Society
Aug 10, 2016·Current Treatment Options in Oncology·Hans-Georg Wirsching, Michael Weller
Aug 27, 2016·Neuro-oncology·Colin Watts, Karl-Josef Langen
Oct 28, 2016·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Satoshi OgasawaraYukinari Kato
Dec 30, 2016·Nature Reviews. Clinical Oncology·Guido ReifenbergerMichael Weller
Jan 18, 2017·Acta neurochirurgica·Rouzbeh Banan, Christian Hartmann
Mar 10, 2018·Advances in Anatomic Pathology·José E Velázquez Vega, Daniel J Brat
Jun 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Phedias Diamandis, Kenneth D Aldape
Jun 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentSusan M Chang
May 5, 2018·Advances in Anatomic Pathology·Ruta GuptaSandra A O'Toole
Oct 10, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H G VuongT Kondo
Aug 28, 2018·The International Journal of Neuroscience·Ravindra Pramod DeshpandePhanithi Prakash Babu
Dec 5, 2018·Cancer·Marjolein Geurts, Martin J van den Bent
Nov 24, 2018·Journal of Neuro-oncology·Daniel DelevOliver Schnell
Feb 12, 2019·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·David ScheieMorten Grauslund
Feb 20, 2016·Experimental and Therapeutic Medicine·Lei WangYinan Luo
Oct 12, 2017·Journal of Oncology Practice·Joo Yeon Nam, John F de Groot
Dec 6, 2019·Journal of Neuro-oncology·Emma van KesselPierre A Robe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.